Cargando...

Intravesical Bacillus Calmette‐Guérin in Ta and T1 bladder cancer

BACKGROUND: Intravesical therapy with Bacillus Calmette‐Guérin (BCG) aims to reduce the incidence of tumour recurrence following transurethral resection (TUR) for patients with superficial bladder cancer. OBJECTIVES: The objective of this review was to compare the incidence of tumour recurrence afte...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Autores principales: Shelley, Mike, Court, J B, Kynaston, H, Wilt, Timothy J, Fish, Reg, Mason, Malcolm
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Ltd 2000
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7017976/
https://ncbi.nlm.nih.gov/pubmed/11034738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001986
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!